These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28284731)

  • 1. Changes in Asthma Maintenance Therapy Prescribing Patterns Following the 2006 Long-acting β-Agonist FDA Drug Warning.
    Winter JD; Reetz MR; Kerns JW; Winter KM; Sabo RT; Krugman SD
    Clin Ther; 2017 Apr; 39(4):697-701. PubMed ID: 28284731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
    Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
    Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in long-acting β-agonist utilization after the FDA's 2010 drug safety communication.
    Hartung DM; Middleton L; Markwardt S; Williamson K; Ketchum K
    Clin Ther; 2015 Jan; 37(1):114-123.e1. PubMed ID: 25465946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study.
    Thomas M; Murray-Thomas T; Fan T; Williams T; Taylor S
    BMC Pulm Med; 2010 May; 10():29. PubMed ID: 20470409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-acting beta-agonist controversy: a clinical dilemma.
    Lang DM; Davis RS
    Allergy Asthma Proc; 2007; 28(2):136-44. PubMed ID: 17479596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
    Chung KF; Caramori G; Adcock IM
    Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
    Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L
    Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study.
    Ortega VE; Hawkins GA; Moore WC; Hastie AT; Ampleford EJ; Busse WW; Castro M; Chardon D; Erzurum SC; Israel E; Montealegre F; Wenzel SE; Peters SP; Meyers DA; Bleecker ER
    Lancet Respir Med; 2014 Mar; 2(3):204-13. PubMed ID: 24621682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
    Eltonsy S; Forget A; Beauchesne MF; Blais L
    J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The addition of long-acting beta-agonists to inhaled corticosteroids in asthma.
    Sears MR
    Curr Opin Pulm Med; 2011 Jan; 17(1):23-8. PubMed ID: 21045700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
    Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma.
    Perrin K; Williams M; Wijesinghe M; James K; Weatherall M; Beasley R
    J Allergy Clin Immunol; 2010 Sep; 126(3):505-10. PubMed ID: 20816187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription patterns in asthma patients initiating salmeterol in UK general practice: a retrospective cohort study using the General Practice Research Database (GPRD).
    DiSantostefano RL; Davis KJ
    Drug Saf; 2011 Jun; 34(6):511-20. PubMed ID: 21585223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting β-agonist prescribing in people with asthma in primary care.
    Morales DR; Jackson C; Fielding S; Guthrie B
    Thorax; 2013 Feb; 68(2):192-4. PubMed ID: 22942016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.